Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SOMATROGON-GHLA: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

36.4%
Female
63.6%
Male

Age Information

The average age of patients reporting adverse events with SOMATROGON-GHLA is 10.3 years.

Geographic Distribution

The majority of adverse event reports for SOMATROGON-GHLA originate from JP.

Report Summary & Outcomes

1,057
Total Reports
1,057
As Primary/Secondary Suspect
2
Deaths Reported
36
Hospitalizations
5
Life-Threatening
4
Disabilities

Reporting Timeline

First adverse event report: 20220101. Most recent report: 20250925. View full timeline →

More About SOMATROGON-GHLA

SOMATROGON-GHLA Full Profile Reports by Year Drug Interactions